Logo

BioMicro Systems Closes Series B Funding, Plans to Broaden Product Line

Sep 27, 2007
NEW YORK (GenomeWeb News) - BioMicro Systems said today it has closed a round of Series B financing with investors vSpring, Nanostart, and Staley Capital Advisors.
 
BioMicro, which markets the MAUI hybridization product line, did not disclose the amount of funding it received in this round, but said the new investments bring the total it has raised since inception to $10 million.
 
Company CEO Michael Feldman said BioMicro plans to use the money to "broaden our product portfolio to include Kreatech reagents, Arrayjet microarrayers and soon-to-be-announced new products."

Breaking News
The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.